Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- September 1, 2018
published in
- JAMA internal medicine Journal
has subject area
- Amputation
- Blood Glucose
- Canagliflozin
- Diabetes Mellitus, Type 2
- Dipeptidyl-Peptidase IV Inhibitors
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Glucagon-Like Peptide 1
- Humans
- Incidence
- Lower Extremity
- Male
- Middle Aged
- Peripheral Arterial Disease
- Population Surveillance
- Propensity Score
- Retrospective Studies
- Sodium-Glucose Transporter 2 Inhibitors
- United States